BioVie
  • BioVie (OTC PINK: BIVI)
  • About
    • Management Team
    • Medical advisory board
    • IND Team
    • Consultant network
  • Disease Target
    • Ascites
    • Severe complications
    • Current drug therapies
    • How does ascites develop?
  • Technology
    • BIV201 development status
    • Future possibilities
    • Potential access to early-stage compounds
    • Efflux pump antibiotics program
    • Forward looking statements
  • Investors
    • Financial Information
    • Press Releases
  • Contact
    • Contact Us
  • Search
Subscribe to Our Email List
Be the first to receive breaking news!

SITE MAP

  • BioVie (OTC PINK: BIVI)
  • About
    • Management Team
    • Medical advisory board
    • IND Team
    • Consultant network
  • Disease Target
    • Ascites
    • Severe complications
    • Current drug therapies
    • How does ascites develop?
  • Technology
    • BIV201 development status
    • Future possibilities
    • Potential access to early-stage compounds
    • Efflux pump antibiotics program
    • Forward looking statements
  • Investors
    • Financial Information
    • Press Releases
  • Contact
    • Contact Us

FOR INQUIRIES

Investors
info@biovieinc.com

Business Development
info@biovieinc.com

Media
info@biovieinc.com

CONNECT WITH US

Facebook

Twitter

Contact Us

Subscribe to our email list

Subscribe to Our Email List
Be the first to receive breaking news!

Contact Info

BioVie Inc.
100 Cummings Center, Suite 247-C
Beverly, Massachusetts 01915
info@biovieinc.com
© 2016 Copyright - BioVie | Terms and Conditions | Privacy Policy
Scroll to top